SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-019669
Filing Date
2023-03-17
Accepted
2023-03-17 16:36:02
Documents
1
Period of Report
2023-03-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6606
  Complete submission text file 0001209191-23-019669.txt   8064
Mailing Address C/O JAVELIN PHARMACEUTICALS, INC. 125 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address
Tulipano Stephen J (Reporting) CIK: 0001360548 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38938 | Film No.: 23743194

Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Issuer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations